GlassScriptPhysician profile
Mujahid A Hines
NPI 1083806541
$15,179.94
in general payments reported to CMS, 2019-2025
26 companies · $3,335 in 2025
The $3,335 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $1,961 · 2021: $1,332 · 2022: $2,219 · 2023: $2,040 · 2024: $4,005 · 2025: $3,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,980 · Consulting Fee: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,979.95 |
| Consulting Fee | $1,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,577.99 | 2019-2025 | Clareon, Wavelight Refractive Suite, Centurion |
| New World Medical,INC. | $2,383.92 | 2021-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Glaukos Corporation | $1,816.44 | 2024-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Idose |
| Glaxosmithkline, LLC. | $1,625.00 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $810.05 | 2024-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Biotissue Holdings INC. | $777.39 | 2020-2025 | |
| Rxsight INC | $517.54 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $305.31 | 2022-2025 | Tyrvaya |
| Carl Zeiss Meditec, INC. | $275.00 | 2021 | |
| Bausch & Lomb Americas INC. | $208.80 | 2024-2025 | Miebo, Scoutpro Osmolarity System, Stellaris |
| Abbvie INC. | $129.16 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $121.38 | 2020 | |
| Allergan, INC. | $109.64 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $92.69 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $85.72 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $73.44 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $59.47 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Thea Pharma INC. | $40.20 | 2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $27.28 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.21 | 2021 | |
| Mallinckrodt Hospital Products INC. | $23.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.34 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.66 | 2019 | |
| Shire North American Group INC | $18.04 | 2019 | |
| Horizon Therapeutics Plc | $17.87 | 2021 | |
| Eyevance Pharmaceuticals LLC | $16.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mujahid Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.